Cognitive Enhancement

  • Kathleen M. Kantak
  • Joseph G. Wettstein

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 228)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Basic Approaches and Perspectives

    1. Front Matter
      Pages 1-3
    2. Philip D. Harvey, Richard S. E. Keefe
      Pages 5-25
    3. Tanya L. Wallace, Theresa M. Ballard, Courtney Glavis-Bloom
      Pages 27-57
    4. Caroline Ménard, Pierrette Gaudreau, Rémi Quirion
      Pages 59-98
  3. Cognitive Domains for Pharmacological Intervention: Implications for Neuropsychiatric and Neurological Illnesses

    1. Front Matter
      Pages 157-159
    2. Patrick M. Callahan, Alvin V. Terry Jr.
      Pages 161-189
    3. John Talpos, Mohammed Shoaib
      Pages 191-213
    4. Wim J. Riedel, Arjan Blokland
      Pages 215-236
    5. Tomiki Sumiyoshi
      Pages 237-247
    6. Karim Nader
      Pages 249-270
    7. Alexandra Patin, René Hurlemann
      Pages 271-303
  4. Developmental Disorders, Alternative Approaches, and Emerging Technologies

    1. Front Matter
      Pages 305-307
    2. Arshya Vahabzadeh, Samantha M. Landino, Beate C. Finger, William A. Carlezon Jr., Christopher J. McDougle
      Pages 309-334
    3. Jane R. Taylor, Mary M. Torregrossa
      Pages 381-415
    4. Krishnakanth Kondabolu, Marek Mateusz Kowalski, Erik Andrew Roberts, Xue Han
      Pages 441-450
    5. Kathleen M. Kantak, Joseph G. Wettstein
      Pages 451-459
  5. Back Matter
    Pages 461-470

About this book


This book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement.


Alzheimer's Disease Neuroenhancement attention deficit hyperactivity disorder autism bipolar disorder depression

Editors and affiliations

  • Kathleen M. Kantak
    • 1
  • Joseph G. Wettstein
    • 2
  1. 1.Department of Psychological and Brain SciencesBoston UniversityBostonUSA
  2. 2.Roche Pharmaceutical Research and Early Development; Neuroscience, Ophthalmology and Rare DiseasesF. Hoffmann-La Roche Ltd.BaselSwitzerland

Bibliographic information